Oppenheimer Reaffirms Its Outperform Rating on argenx SE (ARGX)

Argenx SE (NASDAQ:ARGX) is one of the 13 Best Quality Stocks to Buy According to Hedge Funds, supported by hedge fund interest and significant Profit Margin.

Oppenheimer Reaffirms Its Outperform Rating on argenx SE (ARGX)

On September 18, following the company’s ARGX-119 R&D Spotlight event, Oppenheimer reaffirmed its Outperform rating on argenx SE (NASDAQ:ARGX), citing encouraging clinical proof-of-concept evidence in congenital myasthenic syndromes (CMS), a group of rare hereditary conditions that cause fatigue and muscle weakness. It is anticipated that the findings will support the start of an ARGX-119 registration trial in 2026.

Oppenheimer also mentioned argenx SE (NASDAQ:ARGX)’s ARGX-119’s potential uses in spinal muscular atrophy (SMA), where a Phase 2 trial is expected to start by year’s end, and amyotrophic lateral sclerosis (ALS), where Phase 2a topline results are expected in the first half of 2026.

The occasion emphasized argenx SE (NASDAQ:ARGX)’s dedication to first-in-class development and scientific rigor, solidifying the company’s standing as a core biotech holding and showcasing its approach to developing treatments for neuromuscular and autoimmune disorders around the world.

A commercial-stage biopharma company, argenx SE (NASDAQ:ARGX) is creating treatments for autoimmune diseases in the US, Japan, China, the Netherlands, and abroad. These treatments include VYVGART and VYVGART HYTRULO for immune thrombocytopenia, chronic inflammatory demyelinating polyneuropathy, and generalized myasthenia gravis. It is one of the best quality stocks.

While we acknowledge the potential of ARGX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ARGX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 15 Stocks That Will Benefit From AI and 14 Best IT Stocks to Buy for the Long Term.

Disclosure: None.